Estrella Immunopharma Inc Share Price Today: Live Updates & Key Insights
Estrella Immunopharma Inc share price today is $0.78, up 2.04%. The stock opened at $0.8 against the previous close of $0.7644, with an intraday high of $0.81 and low of $0.732.
Estrella Immunopharma Inc Share Price Chart
Estrella Immunopharma Inc
Estrella Immunopharma Inc Share Price Performance
Estrella Immunopharma Inc Institutional Holdings
Estrella Immunopharma Inc Market Status
Estrella Immunopharma Inc Fundamentals
Market Cap 32.90 M
PB Ratio 4.1327
PE Ratio 0.0
Enterprise Value 30.82 M
Total Assets 3.18 M
Volume 78744
Estrella Immunopharma Inc Company Financials
About Estrella Immunopharma Inc & investment objective
Company Information Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in Phase I/II clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It offers ARTEMIS, a cell receptor platform to develop and commercialize T-cell therapies targeting CD19 and CD22 for the treatment of hematologic malignancies. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California. Estrella Immunopharma, Inc. is a subsidiary of Eureka Therapeutics, Inc.
Organisation Biotechnology
Employees 0
Industry Biotechnology
CEO Dr. Cheng Liu Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Estrella Immunopharma Inc FAQs
What is the share price of Estrella Immunopharma Inc today?
The current share price of Estrella Immunopharma Inc is $0.78.
Can I buy Estrella Immunopharma Inc shares in India?
Yes, Indian investors can buy Estrella Immunopharma Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Estrella Immunopharma Inc shares in India?
You can easily invest in Estrella Immunopharma Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Estrella Immunopharma Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Estrella Immunopharma Inc.
Can I buy fractional shares of Estrella Immunopharma Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Estrella Immunopharma Inc?
Estrella Immunopharma Inc has a market cap of $32.90 M.
In which sector does Estrella Immunopharma Inc belong?
Estrella Immunopharma Inc operates in the Biotechnology sector.
What documents are required to invest in Estrella Immunopharma Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Estrella Immunopharma Inc?
The PE ratio of Estrella Immunopharma Inc is N/A and the PB ratio is 4.13.